Clinical Trials Directory

Trials / Completed

CompletedNCT03950531

The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD

The Effect of Bronchiectasis on the Exacerbation and Mortality of Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Study type
Observational
Enrollment
122 (actual)
Sponsor
Ministry of Health, Turkey · Other Government
Sex
All
Age
40 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the airways and lungs that develops against harmful particles or gases with exacerbations. Coexistence of bronchiectasis with COPD may lead to worsening of the functional parameters as well as alteration of the microbiological pattern in exacerbations and may negatively affect the exacerbation result parameters.

Detailed description

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the airways and lungs that develops against harmful particles or gases with exacerbations. COPD exacerbations are characterized by worsening of dyspnea, coughing and expectoration. Exacerbations requiring hospitalization are the main cause of morbidity and mortality in COPD. Bronchiectasis is the irreversible extension of the bronchi. Usually follows with chronic sputum cough, airway obstruction and recurrent infection episodes. The association of bronchiectasis and COPD has long been known and its incidence is in the range of 30-50%. Coexistence of bronchiectasis with COPD may lead to worsening of the functional parameters as well as alteration of the microbiological pattern in exacerbations and may negatively affect the exacerbation result parameters.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2010-01-25
Primary completion
2014-12-25
Completion
2017-01-25
First posted
2019-05-15
Last updated
2019-05-17

Source: ClinicalTrials.gov record NCT03950531. Inclusion in this directory is not an endorsement.